CanStix™ [Polystyrene-NitriloTriAcetic Acid-Ferric/Ferrous ]

                                          Latex agglutinin particles, for early cancer detection

  • Sample: 10g Epithelial Cell
  • Duration of Test:  3-5 hours/5 samples
  • Test Standard: Proteomics (see protocol): The identification, and quantification of Atypical Human Transferrin Receptors (AHTR)  extracted from BioMarkers form the basis for diagnosis of cancers (see references) in organs like:

                Cervical

             Prostate

             Breast

             Pancreatic

             Lung

             Colon/Recal

             Leukemia

           Bone

             Liver

             Skin

BioMarkers have been FDA approved for various formates and claims. Assay also meets American Society for Clinical Pathology (ASCP) and FDA guidlines and regulations for Quality Assurance (QA), and FDA ICH QSE and EOP2 biochemical activity assay testing.. 

  • Reagent Composition: 0.5-mg CanStix™ Resin/sample; Buffers A/B/C
  • Test Property(see protocol):
  • *Assay Sensitivity: 99.9%
  • *Assay Specificity: 93%
  • *Assay Positive Predictive Value: 91%
  • *Negative Predictive Value: 99.9%

 

*Notes: outcomes subject to external,internal, and construct variations. Detection possible in tumors as early as 3 months.

Document Library

NameDescription
DocumentEarly Cancer DiagnosticsPolanski et al 2006. A list of candidate cancer BioMarkers for Targeted Proteomics. BioMarker Insights 2.
DocumentEarly Cancer Detection TechniquesAkhter et al. 2010. Proteomics: an evolving technology in Laboratory Medicine. Internet Journal of Medical Update. January 2010: 5(1): 35-41
DocumentEarly Cancer Detection TechniquesSeibert et al 2005. Advances in clinical cancer proteomics: SELDI-TOF MASS Spectrometry and biomarker discovery. Breifings in functional genomics and proteomics. 4(1) 16-26 May
DocumentEarly Detection of Cancer Using Transferrin ReceptorHogemann-Savellano et al 2003. The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer. Neoplasia 5(6) 495-506
DocumentEarly Detection of Gastric CancerJin-Woo Ryu et al 2003.The Proteomics Approach to Find Biomarkers in Gastric Cancer. J Korean Med Sci 2003; 18: 505-9
DocumentEarly Detection of Cancer using TransferrinChoi et al 2010. Mechanism for active targeting in solid tumors with transferrin-containing gold nanoparticles. PANS 107(3)1235-1240
DocumentDetection of Colon Cancer Using ProteomicsWard et al 2006. Identification of serum biomarkers for colon cancer by proteomic analysis. British Journal of Cancer 94 1898-1905
DocumentDetection of Cancer using Transferrin BioMarkerAloj et al. 1996. Evaluation of Human Transferrin Radiolabelled with N-Succinimidyl 4-{Fluorine-18](Fluoromethyl) Benzoate. Journal of Nuclear Medicine. 37 p.1408-1412
DocumentCanStix Resin TechnologyUS Patent for use of in Proteomics and Genomics
DocumentCanstix Resin TechnologyUS Library of Congress Copyrights for Synthesis and use in proteomics